Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis

European Journal of Neurology

Volumn 16, Issue 2, 2009, Pages 262-267

  Putzki, N ^a,b,c   Pfriem, A ^b   Limmroth, V ^b   Yaldizli, O ^c   Tettenborn, B ^c   Diener, H C ^b   Katsarava, Z ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

Glatirameracetate; Headache; Interferon beta; Multiple sclerosis; Pain; Trigeminal neuralgia

Indexed keywords

BETA INTERFERON; GLATIRAMER;

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENT DISEASE; REMISSION; TENSION HEADACHE; TRIGEMINUS NEURALGIA;

ADULT; AGED; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-BETA; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MULTIPLE SCLEROSIS; PEPTIDES; PREVALENCE; TENSION-TYPE HEADACHE; TRIGEMINAL NEURALGIA;

EID: 58349090714     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02406.x     Document Type: Article

References (47)

1. Archibald CJ, McGrath PJ, Ritvo PG, et al. Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients. Pain 1994 58 : 89 93.
2. Clifford DB, Trotter JL. Pain in multiple sclerosis. Archives of Neurology 1984 41 : 1270 1272.
3. Moulin DE, Foley KM, Ebers GC. Pain syndromes in multiple sclerosis. Neurology 1988 38 : 830 834.
4. Stenager E, Knudsen L, Jensen K. Acute and chronic pain syndromes in multiple sclerosis. Acta Neurologica Scandinavica 1991 84 : 197 200.
5. Freedman MS, Gray TA. Vascular headache: a presenting symptom of multiple sclerosis. Canadian Journal of Neurological Sciences 1989 16 : 63 66.
6. Rolak LA, Brown S. Headaches and multiple sclerosis: a clinical study and review of the literature. Journal of Neurology 1990 237 : 300 302.
7. D'Amico D, La Mantia L, Rigamonti A, et al. Prevalence of primary headaches in people with multiple sclerosis. Cephalalgia 2004 11 : 980 984.
8. Haas DC, Kent PF, Friedman DI. Headache caused by a single lesion of multiple sclerosis in the periaqueductal gray area. Headache 1993 33 : 452 455.
9. Fragoso YD, Brooks JB. Two cases of lesions in brainstem in multiple sclerosis and refractory migraine. Headache 2007 47 : 852 854.
10. Alstadhaug K, Breivik K, Rusic Z. Recurrent headache due to MS plaque. Headache 2008 48 : 453 454.
11. Galer BS, Lipton RB, Weinstein S, Bello L, Solomon S. Apoplectic headache and oculomotor nerve palsy: an unusual presentation of multiple sclerosis. Neurology 1990 40 : 1465 1466.
12. Gee JR, Chang J, Dublin AB, Vijayan N. The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis. Headache 2005 45 : 670 677.
13. Rieckmann P, Toyka KV. Escalating immunotherapy of multiple sclerosis.Austrian-German-Swiss Multiple Sclerosis Therapy Consensus Group [MSTCG]. European Neurology 1999 42 : 121 127.
14. The IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993 43 : 655 661.
15. Jacobs LD, Cookfair DL, Rudick RA, et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Annals of Neurology 1996 39 : 285 294.
16. Mantia La, Amico DD', Rigamonti A, Mascoli N, Bussone G, Milanese C. Interferon treatment may trigger primary headaches in multiple sclerosis patients. Multiple Sclerosis 2006 12 : 476 480.
17. Pöllmann W, Erasmus LP, Feneberg W, Then Berg F, Straube A. Interferon beta but not glatiramer acetate therapy aggravates headaches in MS. Neurology 2002 9 : 636 639.
18. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology 1983 13 : 227 231.
19. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology 2001 50 : 121 127.
20. Katsarava Z, Obermann M, Yoon MS, Kuznetsova J, Weimar C, Diener CH. Prevalence of cluster headache in a population-based sample in Germany. Cephalalgia 2007 27 : 1014 1019.
21. Fritsche G, Hueppe M, Kukava M, et al. Validation of a german language questionnaire for screening for migraine, tension-type headache, and trigeminal autonomic cephalgias. Headache 2007 47 : 546 551.
22. Yoon MS, Obermann M, Fritsche G, et al. Population-based validation of a German-language self-administered headache questionnaire. Cephalalgia 2008 28 : 605 608.
23. Putzki N, Katsarava Z, Vago S, Diener HC, Limmroth V. Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients. European Neurology 2008 59 : 136 142.
24. Putzki N, Knipp S, Ramczykowski T, et al. Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis. Multiple Sclerosis 2006 12 : 363 366.
25. Kalman B, Lublin FD. Spectrum and classification of inflammatory demyelinating diseases of the central nervous system. Current Neurology Neuroscience Reports 2001 1 : 249 256.
26. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983 33 : 1444 1452.
27. Martinelli Boneschi F, Colombo B, Annovazzi P, et al. Lifetime and actual prevalence of pain and headache in multiple sclerosis. Multiple Sclerosis 2008 14 : 514 521.
28. Göbel H, Petersen-Braun M, Soyka D. The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia 1994 14 : 97 106.
29. Lampl C, Buzath A, Baumhackl U, Klingler D. One-year prevalence of migraine in Austria: a nation-wide survey. Cephalalgia 2003 23 : 280 286.
30. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007 68 : 343 349.
31. Lantéri-Minet M, Valade D, Géraud G, Chautard MH, Lucas C. Migraine and probable migraine - results of FRAMIG 3, a French nationwide survey carried out according to the 2004 IHS classification. Cephalalgia 2005 25 : 1146 1158.
32. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. Journal of American Medical Association 1992 267 : 64 69.
33. Zivadinov R, Willheim K, Sepic-Grahovac D, et al. Migraine and tension-type headache in Croatia: a population-based survey of precipitating factors. Cephalalgia 2003 23 : 336 343.
34. Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. Journal of American Medical Association 1998 279 : 381 383.
35. Rasmussen BK, Jensen R, Olesen J. A population-based analysis of the diagnostic criteria of the International Headache Society. Cephalalgia 1991 11 : 129 134.
36. Harris W. Rare forms of paroxysmal trigeminal neuralgia, and their relation to disseminated sclerosis. British Medical Journal 1950 2 : 1015 1019.
37. Ruge D, Brochner D, Davis L. A study of the treatment of 637 patients with trigeminal neuralgia. Journal of Neurosurgery 1958 15 : 528 536.
38. Rushton JG, Olafson RA. Trigeminal neuralgia associated with multiple sclerosis. A case report. Archives of Neurology 1965 13 : 383 386.
39. Solaro C, Brichetto G, Amato MP, et al., PaIMS Study Group. The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. Neurology 2004 63 : 919 921.
40. da Silva CJ, da Rocha AJ, Mendes MF, Maia AC Jr., Braga FT, Tilbery CP. Trigeminal involvement in multiple sclerosis: magnetic resonance imaging findings with clinical correlation in a series of patients. Multiple Sclerosis 2005 11 : 282 285.
41. van der Meijs AH, Tan IL, Barkhof F. Incidence of enhancement of the trigeminal nerve on MRI in patients with multiple sclerosis. Multiple Sclerosis 2002 8 : 64 67.
42. MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000 123 : 665 676.
43. Manzoni GC, Torelli P. Epidemiology of typical and atypical craniofacial neuralgias. Neurological Sciences 2005 26 : s65 s67.
44. Vacca G, Marano E, Brescia Morra V, et al. Multiple sclerosis and headache co-morbidity. A case-control study. Neurological Sciences 2007 28 : 133 135.
45. Pöllmann W, Erasmus LP, Feneberg W, Straube A. The effect of glatiramer acetate treatment on pre-existing headaches in patients with MS. Neurology 2006 66 : 275 277.
46. Feuillet L, Reuter F, Audoin B, et al. Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Multiple Sclerosis 2007 13 : 124 127.
47. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004 24 (Suppl. 1 9 160.